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Several findings have indicated an involvement of dopamine in panic and defensive
behaviors. The dorsolateral column of the periaqueductal gray (dlPAG) is crucially involved
in the expression of panic attacks in humans and defensive behaviors, also referred to
as panic-like behaviors, in animals. Although the dlPAG is known to receive a specific
innervation of dopaminergic fibers and abundantly expresses dopamine receptors, the
origin of this dopaminergic input is largely unknown. This study aimed at mapping the
dopaminergic projections to the dlPAG in order to provide further insight into the panic-like
related behavior circuitry of the dlPAG. For this purpose, the retrograde tracer cholera
toxin subunit b (CTb) was injected into the dlPAG of male Wistar rats and double
immunofluorescence for CTb and tyrosine hydroxylase (TH), the rate-limiting enzyme in
the synthesis of dopamine, was performed. Neurons labeled for both CTb and TH were
counted in different dopaminergic cell groups. The findings indicate that the dopaminergic
nerve terminals present in the dlPAG originate from multiple dopamine-containing cell
groups in the hypothalamus and mesencephalon. Interestingly, the A13 cell group is the
main source of dopaminergic afferents to the dlPAG and contains at least 45% of the
total number of CTb/TH-positive neurons. Anterograde tracing with biotinylated dextran
amine (BDA) combined with double immunofluorescence for BDA and TH confirmed the
projections from the A13 cell group to the dlPAG. The remainder of the dopamine-positive
terminals present in the dlPAG was found to originate from the extended A10 cell group
and the A11 group. The A13 cell group is known to send dopaminergic efferents to several
other brain regions implicated in defensive behavior, including the central amygdala and
ventromedial hypothalamus. Therefore, although direct behavioral evidence is lacking, our
finding that the A13 cell group is also the main source of dopaminergic input to the dlPAG
suggests that dopamine might contribute to the regulation of dlPAG-mediated defensive
behaviors.
Keywords: dorsolateral periaqueductal gray (dlPAG), dopamine, incertohypothalamic A11, and A13 cell groups,
defensive behavior, panic
Abbreviations: 3N, oculomotor nucleus; 3PC, oculomotor nucleus, parvicel-
lular part; 3V, 3rd ventricle; a, artery; A11, A11 dopamine cells; A13, A13
dopamine cells; AHP, anterior hypothalamic area, posterior part; Aq, aque-
duct; BDA, biotinylated dextran amine; bsc, brachium of the superior colliculus;
csc, commissure of the superior colliculus; DA, dorsal hypothalamic area; Dk,
nucleus of Darkschewitsch; DLPAG, dorsolateral periaqueductal gray; DMC, dor-
somedial hypothalamic nucleus, compact part; DMD, dorsomedial hypothalamic
nucleus, dorsal part; DMPAG, dorsomedial periaqueductal gray; DMV, dorsome-
dial hypothalamic nucleus, ventral part; DpG, deep gray layer of the superior
colliculus; DpMe, deep mesencephalic nucleus; DpWh, deep white layer of the
superior colliculus; DT, dorsal terminal nucleus of the accessory optic tract; dtgd,
dorsal tegmental decussation; EW, Edinger-Westphal nucleus; f, fornix; fr, fascicu-
lus retroflexus; IF, interfascicular nucleus; IGP, internal globus pallidus (intrape-
duncular nucleus); InC, interstitial nucleus of Cajal; InCSh, interstitial nucleus of
Cajal. shell region; InG, intermediate gray layer of the superior colliculus; InWh,
intermediate white layer of the superior colliculus; LPAG, lateral periaqueduc-
tal gray; Lth, lithoid nucleus; MA3, medial accessory oculomotor nucleus; MGM,
medial geniculate nucleus, medial part; ml, medial lemniscus; mlf, medial longitu-
dinal fasciculus; MPT, medial pretectal nucleus; mt, mammillothalamic tract; mtg,
mammillotegmental tract; MTu, medial tuberal nucleus; mZI, medial zona incerta;
opt, optic tract; PaC, paracommissural nucleus of the posterior commissure; PAG,
periaqueductal gray; PaR, pararubral nucleus; PaXi, paraxiphoid nucleus of thala-
mus; PBP, parabrachial pigmented nucleus of the VTA; pc, posterior commissure;
PCom, nucleus of the posterior commissure; PeF, perifornical nucleus; PeF, peri-
fornical nucleus; PeFLH, perifornical part of lateral hypothalamus; PHA, posterior
hypothalamic area; PHD, posterior hypothalamic area, dorsal part; PIL, poste-
rior intralaminar thalamic nucleus; PLH, peduncular part of lateral hypothalamus;
PR, prerubral field; PVG, periventricular gray; RLi, rostral linear nucleus of the
raphe; RMC, red nucleus, magnocellular part; RPC, red nucleus, parvicellular part;
RPF, retroparafascicular nucleus; SC, superior colliculus; SCO, subcommissural
organ; scp, superior cerebellar peduncle (brachium conjunctivum); SG, supra-
geniculate thalamic nucleus; SNCD, substantia nigra, compact part, dorsal tier;
SNL, substantia nigra, lateral part; SNR, substantia nigra, reticular part; Stg,
stigmoid hypothalamic nucleus; Su3, supraoculomotor periaqueductal gray; Su3C,
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INTRODUCTION
There is considerable evidence supporting a role for dopamine in
defensive behavior and panic. Early animal studies have shown
the contribution of dopamine in the general process of defen-
sive behavior, suggesting a facilitating role for dopamine via its
D2-receptors. Systemic administration of D2-receptor agonists
has been shown to induce defensive and aggressive reactions
whereas D2-receptor antagonists reduce these types of behav-
ior (Maeda, 1976; Maeda et al., 1985; Puglisi-Allegra and Cabib,
1988a,b; Gendreau et al., 1998, 2000). Additionally, systemic
administration of the dopamine receptor antagonists haloperidol
and chlorpromazine increases the threshold of hypothalamic-
induced directed attack and threat responses, while agonists
such as methamphetamine and apomorphine, which enhance
dopaminergic transmission, lower this threshold (Maeda, 1976;
Maeda et al., 1985). Dopamine densely innervates several regions
of the defensive behavior system such as the amygdala and
hypothalamus (Lindvall et al., 1984; Asan, 1998). It is likely
that dopamine release into these brain structures directly par-
ticipates in the facilitation of defensive behavior and panic-like
reactions. For instance, an activation of D2-receptors within
the medial preoptic-anterior hypothalamus has been shown to
induce defense-like reactions in cat (Sweidan et al., 1991).
The dorsolateral column of the periaqueductal gray (dlPAG) is
another key structure of the defensive behavior system (Bandler
and Shipley, 1994; Del-Ben and Graeff, 2009; Fogaça et al., 2012).
It responds to the presence of proximal threat (Reiman et al.,
1989; Mobbs et al., 2007) and its stimulation elicits panic attack
and defensive behaviors in both human and animal subjects
(Nashold et al., 1969; Bandler et al., 1985; Deakin and Graeff,
1991; Jenck et al., 1995; Adams, 2006). An interesting study from
Jenck et al. (1990) demonstrated that nomifensine, a dopamine-
and noradrenaline-reuptake inhibitor, enhances the aversion
induced by electrical stimulation of the dorsal PAG, suggesting a
role for dopamine within this region. The presence of dopamine
fibers and dopamine D2-receptor in the dlPAG has been shown in
rat and in cat (Mansour et al., 1990; Kitahama et al., 2000, 2007).
Taken together, these findings suggest that dopamine might par-
ticipate in regulating the expression of dlPAG-mediated panic-like
behaviors.
A first step to answer this question is to establish a map
of dopaminergic afferents to this region. Therefore, this study
aimed first at investigating the existence of a dopaminergic inner-
vation into the dlPAG by applying immunohistochemistry for
tyrosine hydroxylase (TH) and dopamine-β-hydroxylase (DBH),
the rate-limiting enzymes in the synthesis of dopamine and
noradrenaline respectively, to distinguish between dopaminergic
fibers (TH positive) and (nor)adrenergic fibers (TH and DBH
positive). Subsequently, to determine the source of dopamin-
ergic neurons projecting to the dlPAG, the retrograde tracer
cholera toxin subunit b (CTb) was injected into the dlPAG, and
supraoculomotor cap; SubB, subbrachial nucleus; SubG, subgeniculate
nucleus; SubI, subincertal nucleus; Te, terete hypothalamic nucleus; ts, tec-
tospinal tract; vPAG, ventral PAG; VTAR, ventral tegmental area, rostral part;
ZI, zona incerta; ZIC, zona incerta, caudal part; ZID, zona incerta, dorsal part;
ZIR, zona incerta, rostral part; ZIV, zona incerta, ventral part; Zo, zona layer
of the superior colliculus.
immunofluorescence for CTb and TH was examined in several
dopaminergic cell groups. The anterograde tracer biotinylated
dextran amine (BDA) was used to confirm the findings obtained
with the retrograde tracing experiments. We investigated the dis-
tribution and localization of dopaminergic cells projecting to the
dlPAG, and showed that they originate from distinct dopaminer-
gic cell groups.
EXPERIMENTAL PROCEDURES
ANIMALS
Twenty male Wistar rats (250–300 g at the time of surgery)
from Harlan, The Netherlands, were group-housed (2 or 3
rats per cage) and maintained on a 12-h/12-h light/dark cycle
(lights on 0700-1900 h) with ad libitum access to food and
water. All experimental procedures were in compliance with the
European Communities Council Directive of 24 November 1986
(86/609/EEC) and approved by the Institutional Animal Care and
Use Committee of the University of Groningen, The Netherlands.
GENERAL SURGICAL PROCEDURES
Nineteen rats were anesthetized by isoflurane inhalation (5% in
800ml/min oxygen) and positioned in a stereotaxic apparatus
(Kopf Instruments, Tujunga, CA, USA), fitted with a nose cone
allowing for the continuous administration of anesthetic. After
the rat was placed in the stereotaxic apparatus, the percentage
of isoflurane was lowered to 2.5%. After cleaning of the sur-
face, an incision was made in the skin covering the skull, and
burr holes were drilled in the skull overlying the region of inter-
est. Tracer injections were made stereotaxically, using coordinates
taken from the rat brain atlas of Paxinos and Watson (1998).
Subsequently, the wound was sutured and cleaned. After surgery,
the rats received a subcutaneous injection of the non-steroidal
analgesic carprofen (4mg/kg; Pfizer, NY, USA) and were allowed
to recover from anesthesia in individual cages placed on a heating
pad for 1 h. The following day, they received a second injection of
carprofen (4mg/kg).
Injection of retrograde tracer
CTb (2%, List Biological Laboratories, Campbell, CA, USA),
dissolved in distilled water, was targeted into the right dlPAG
(coordinates: 6.3–6.6mm posterior to Bregma, 1.6mm lateral to
the midline, 4.4–4.9mm from the surface of the dura mater, angle
15◦) of 13 animals. The tracer was delivered into the targeted
area through a glass micropipette, either by pressure injection
(pipette tip diameter 20–30μm; volume ranged between 20 and
75 nl) using an automated air-pressure system (World Precision
Instruments PV830, Sarasota, FL, USA), or by iontophoresis
(pipette tip diameter 10–20μm) using a 5–μA positive-pulsed
current (7 s on/off circles for 20min). To avoid leakage of tracer
along the pipette track, the pipette was left in place after the
pressure injection for 5–10min, and after the iontophoresis injec-
tion for 10min with negative current. Out of 13 cases, six cases
(R22, R23, R25, R26, R29, R30) were selected for the quantitative
analysis.
Injection of anterograde tracer
In order to certify the projections found with the above-described
retrograde tracing technique, anterograde projections originating
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from the region that contained most of the double-labeled cell
bodies for CTb and TH were analyzed. The anterograde tracer
BDA (10,000mW, 10%; Molecular Probes, Carlsbad, CA, USA)
was stereotaxically injected into the A13 dopaminergic cell group
located in the medial zona incerta (coordinates: 2.4mm posterior
to Bregma; 2.1mm lateral to the midline; 7.9mm from the sur-
face of the dura mater; angle 10◦) by pressure injection following
the same procedure as described in the section above (pipette tip
diameter 20–30μm; volume ranged between 20 and 75 nl). Out
of six cases, two cases (F424 and F425) with injections that cov-
ered the entire A13 cell group were selected for further qualitative
analysis.
Perfusion and tissue collection
Following a postsurgical survival period of 1 week, rats were anes-
thetized with an overdose of sodium pentobarbital (60mg/kg,
i.p.) and perfused transcardially with 50ml of heparinized (5000
IE/ml) 0.9% (w/v) saline (Leo Pharma, Breda, The Netherlands),
followed by 300ml of 4% (w/v) paraformaldehyde in 0.1M phos-
phate buffer (PB, pH 7.4). The brains were removed, postfixed at
4◦C for 24 h, and then transferred to 25% sucrose in 0.1M PB,
pH 7.4 at 4◦C for 48 h. An incision mark was made on the right
side of the brain, into which tracers were delivered, to allow for
ipsi- and contralateral distinction of projection patterns. Thirty-
μm-thick frozen coronal sections of the entire brain were cut on
a cryostat and collected in five series in Tris-buffered saline (TBS)
with sodium azide (0,01%) and stored at 4◦C until use.
To determine the distribution of TH and DBH in the rat PAG,
one rat was anesthetized and sacrificed according to the same pro-
cedure. The brain tissue was also collected, sectioned and stored
following the same procedure.
IMMUNOHISTOCHEMISTRY
TH and DBH immunohistochemistry
Brain sections containing the dlPAG, obtained from the rat
that did not receive tracer injections, were pretreated with 1%
sodium borohydrate for 15min, rinsed in TBS, treated with
1% hydrogen peroxide in TBS for 1 h, rinsed again in TBS,
preincubated in 5% normal donkey serum (Vector Laboratories,
Burlingame, CA, USA) in 0.3% Triton X-100/TBS for 30min,
and then incubated with a polyclonal rabbit antiserum for TH
(1:1,000; Millipore, Bedford, MA, USA; catalog nr: AB152) or
a monoclonal mouse antiserum for DBH (1:400; Millipore,
Bedford, MA, USA; catalog nr: MAB308) in 1% normal don-
key serum in 0.3% Triton-X/TBS overnight at 4◦C. The next
day, the sections were rinsed in TBS for 90min, incubated with
biotinylated donkey anti-rabbit or donkey anti-mouse (1:1,000;
Jackson ImmunoResearch, West Grove, PA, USA) and rinsed in
TBS for 90min. Subsequently, the sections were incubated with
avidin-biotin peroxidase complex from the Vectastain Elite Kit
(Vector Laboratories, Burlingame, CA, USA). Tissue was rinsed
in TBS for another 90min and the peroxidase product was visu-
alized by transferring sections into 0.022% diaminobenzidine
(Sigma-Aldrich, USA) and 0.003% hydrogen peroxide in TBS
for 5min. The reaction step was terminated by thorough rinsing
in TBS. The sections were then mounted on glass slides, air-
dried, dehydrated in a gradient of alcohol, cleared in xylene, and
cover slipped with DePeX mounting medium (Gurr BDG, Poole,
UK).
Visualization of injection sites
In order to visualize the injection sites, dlPAG sections obtained
from tracer-injected rats were processed following the proce-
dure mentioned above. For this staining, we used a polyclonal
goat antiserum for CTb (1:10,000; List Biological Laboratories,
Campbell, CA, USA; catalog nr: 703) as primary antibody,
biotinylated rabbit anti-goat (1:1,000; Jackson ImmunoResearch,
West Grove, PA, USA) as secondary antibody, and normal rabbit
serum instead of normal donkey serum.
IMMUNOFLUORESCENCE
CTb and TH immunofluorescence
In order to identify the location of retrogradely labeled neu-
rons in the various dopaminergic regions, double labeling for
CTb and TH was performed. The dopaminergic cell groups
have been well described and classified, and have locations very
distinct from the (nor)adrenergic cells groups (Dahlstrom and
Fuxe, 1964; Hökfelt et al., 1984). Therefore, we chose TH as
marker to visualize putative dopaminergic neurons. Three out of
five series of sections of each brain having received CTb injec-
tions were preincubated with 5% normal donkey serum in 0.3%
Triton X-100/TBS for 30min, and then incubated with a cock-
tail of polyclonal rabbit antiserum for TH (1:1,000; Millipore,
Bedford, MA, USA) and polyclonal goat antiserum for CTb
(1:10,000) diluted in 1% normal donkey serum in 0.3% Triton
X-100/TBS overnight at 4◦C. The next day, the sections were
rinsed in TBS for 90min, and incubated with Alexa 568 con-
jugated donkey anti-goat and Alexa 488 conjugated donkey
anti-rabbit (1:500; Jackson ImmunoResearch Laboratories, West
Groves, PA, USA) diluted in 1% normal donkey serum in 0.3%
Triton X-100/TBS for 1 h. After the last incubation step, sec-
tions were rinsed again in TBS for 90min, mounted on gelatin-
coated glass slides, air-dried, cover slipped with Vectashield
mounting medium (Vector Laboratories, Germany) and stored in
the dark.
To control for non-specific staining of the secondary antibod-
ies, the primary antibodies were omitted or replaced with non-
immune serum in some control sections. Virtually no staining
was observed in those sections.
BDA and TH immunofluorescence
In order to certify the findings of the retrograde tracing study and
visualize the dopaminergic fibers in the dlPAG that originate from
the A13 cell group, double labeling for BDA and TH was per-
formed. Sections containing the area of the A13 and the dlPAG
were examined to localize double-labeled soma at the injection
sites (A13 dopaminergic cell group) and double-labeled fibers in
the target area (dlPAG). A one-in-five series of sections was pro-
cessed following the same procedure as described in the previous
paragraph. The same TH (1:1,000) antibody was used, together
with the same secondary antibody or Alexa 633 conjugated don-
key anti-rabbit. BDA labeling was detected with TRITC or Alexa
488 conjugated streptavidin (1:500; Jackson ImmunoResearch
Laboratories, West Grove, PA, USA).
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ANALYSIS
The CTb injection sites of the selected cases (R22.R23.R25.R26.
R29.R30) were drawn using bright field and dark field illumi-
nation with a Zeiss Stemi SV11 microscope. Injection sites and
(double)-labeled cells were visualized with a Leica DM 4000B
fluorescence microscope and double-labeled fibers were exam-
ined with a Leica TCS SP2 confocal microscope. For the CTb/TH
double-staining experiments, CTb-retrogradely labeled and TH-
positive neurons were viewed with excitation lights of 560 nm
wavelength (Leica TX2 filter block) and 480 nmwavelength (Leica
L5 filter block), respectively. For BDA/TH double-stained sec-
tions, BDA labeling was visualized with a TX2 filter and TH
with an L5 filter. Neurons and fibers showing the same mor-
phology, position and orientation under the two different filters
for the detection of CTb and TH, or BDA and TH, in the same
focal plane, were considered to be double labeled. Photographs
were taken with a Leica digital camera DFC 420C. The two-
channel readings for green and red fluorescence were merged by
using Adobe Photoshop, allowing for adjustments in contrast and
brightness.
DOUBLE-LABELED CELL COUNTING
Double-labeled neurons were counted in three-in-five series of
sections for each brain in the different dopaminergic cell groups.
In order to estimate the total number of double-labeled neurons
in each brain, the number for each group and for each subject was
first multiplied by 5/3 (for the dlPAG cases) or 5/1 (for the control
case) to correct for the uncounted sections. The results were then
multiplied by the Abercrombie correction factor in order to cor-
rect for split nuclei and potential double counting (Abercrombie,
1946). The formula is:
A = [t/(t + x)]
Where t equals the thickness of the section (30μm), and x equals
the average diameter of the soma of the dopaminergic neuron. To
measure the diameter of TH-immunoreactive neurons, double-
labeled neurons were captured at high magnification, and the
images were imported into Image J (Bethesda, MD, USA). Using
this software, we determined the size of TH-containing soma and
calculated an average diameter for each dopaminergic group of
each animal. The value of the correction factors ranged from 0.63
to 0.72.
The CTb/TH-positive cells were plotted on sections taken from
the atlas of Paxinos and Watson (1998). The quantification was
expressed in percentage of the total number of labeled cells.
RESULTS
TH AND DBH IMMUNOREACTIVITY IN THE PAG
In order to examine the presence of putative dopaminergic fibers
in the dlPAG, sections were stained with an antibody against
TH and DBH (the rate-limiting enzyme in the synthesis of
noradrenaline). Figure 1A shows a schematic representation of
the PAG observed in the stained sections. Figure 1B shows the
distribution of TH-immunoreactive fibers in the whole PAG.
We observed a uniform and relatively dense presence of TH
immunoreactivity in the different columns of the PAG. As shown
in Figure 1C, DBH-immunoreactive fibers are predominant in
the ventral part of the PAG, whereas they are scarce in the dorsal
part of the PAG. A comparison between TH andDBH immunore-
activity in the dlPAG (outlined in red in Figures 1B,C) indicates
that TH-containing fibers are much more abundant than DBH-
containing fibers, indicating that dopamine is more abundant
than noradrenaline in the dlPAG.
ORIGIN OF TH IMMUNOREACTIVE FIBERS IN THE dlPAG
To determine the origin of the dopaminergic innervation of the
dlPAG, the retrograde tracer CTb was injected into the dlPAG,
and double immunofluorescence for TH and CTb was applied.
Out of the 13 rats that underwent stereotaxic surgery, six rats were
selected for analysis.
CTb injection sites in the dlPAG
Figure 2A shows schematic drawings of pressure CTb injection
sites in the dlPAG, Figure 2B shows an iontophoretic CTb injec-
tion. In five cases the injection was targeted to the dlPAG. In three
FIGURE 1 | Distribution of TH and DBH immunoreactivity in the
PAG. (A) Schematic representation of the PAG and adjacent nuclei.
(B) Micrograph of a coronal section showing TH-labeled fibers and
terminals in the PAG and deep layers of the SC. The dlPAG is outlined
in red; the subdivisions of the PAG are depicted in yellow. (C)
Micrograph of a coronal section showing DBH-labeled fibers and
terminals in the PAG and deep layers of the SC. The dlPAG is outlined
in red. Comparison between Figures 1B,C suggests that dopamine is
more abundant than noradrenaline in the dlPAG. Scale bar is 200μm.
For abbreviations, see list.
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FIGURE 2 | Injection sites of retrograde tracer experiments. (A)
Schematic drawings representing CTb deposits by pressure injections along
the rostro-caudal extent of the dlPAG and the SC. The four cases are
represented by different colors (R22 in red, R23 in brown, R25 in green and
R26 in blue). (B) Schematic representation of CTb iontophoresis deposits in
the dlPAG. R30 is in purple and R29 in dark brown. The injection made in case
R29 was placed in the deep layers of the SC and did not include the dlPAG.
This case was used as a control injection. For abbreviations, see list.
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cases (R22, R23 and R30), the tracer deposits involved a large pro-
portion of the rostro-caudal extent of the dlPAG. In case R22, the
CTb deposit was mainly located in the rostral and intermediate
dlPAG. The tracer was spread into the superior colliculus (SC) at
the level of the rostral dlPAG, and also into the dorsomedial PAG
(dmPAG). In case R23, the injection site covered the intermedi-
ate and caudal parts of the dlPAG as well as the SC at the level of
the intermediate/caudal part of the dlPAG. In case R30, the CTb
deposit was located within the dlPAGwith only minor spread into
the dmPAG. In two other cases (R25 and R26), the injection sites
were more restricted. For case R25, the tracer deposit was con-
tained within the rostral-intermediate dlPAG and SC. In case R26,
the injection site was located in the intermediate-caudal dlPAG
and the deep layers of the SC.
In case R29, the deposit was essentially located within the SC.
This case was used as a control.
Distribution and quantification of CTb/TH double-labeled neurons in
the dopaminergic cell groups
CTb/TH double-labeled neurons were found in several dopamin-
ergic cell groups. In Table 1, the calculated numbers of double-
labeled neurons in the different dopaminergic cell groups are
reported for all the cases. In addition, the relative contribution
of each dopaminergic cell group is indicated as a percentage of
the total number of CTb/TH neurons.
The distribution pattern and proportion of double-labeled
neurons were relatively constant among the different cases,
although there were noticeable differences that might be
explained by a variation in injection size and/or spread of tracer
along the rostro-caudal extent of the dlPAG.
In order to demonstrate the distribution of the putative
dopaminergic neurons projecting to the dlPAG, two cases (R22
and R30) were chosen for illustration (Figures 3–5). Due to their
restricted injection sites, they provide a relatively complete cov-
ering concerning the origin of dopaminergic afferents of the
dlPAG.
A13 cell group. The incertohypothalamic dopaminergic neuron
group (A13) is located in the medial part of the zona incerta
(mZI), in the vicinity of the A14 cell group. In all cases, the A13
cell group was the dopaminergic cell group that contained the
highest number of CTb/TH-positive cells, representing 60% of
the total number of double-labeled cells in R22, 50% in R23, 59%
in R25, 45% in R26, and 78% in R30. CTb/TH-positive neurons
were abundant in the intermediate A13 cell group, whereas only
few double-labeled neurons were found in the rostral and cau-
dal parts. Most of these cells were located at the ipsilateral side
of the tracer injection. Some contralateral double-labeled neu-
rons were found (Figure 3A). This was observed also in cases R23
and R26 which contain higher amounts of tracer (not shown).
Fluorescent images of the A13 cell group show dense clusters of
labeled somata, especially for TH immunostaining with single
CTb and double-labeled cells for CTb and TH (Figure 3B).
A11 cell group. In case R22, there were equal numbers of double-
labeled cells found ipsilaterally and contralaterally to the injection
site (Figure 4A). In case R30, very few neurons (we estimated a
total of 8 neurons) were double labeled and all of themwere found
ipsilateral to the injection site (Figure 4A). In contrast, in case
R25 (in which the injection site wasmore rostral) and case R30 (in
which the CTb deposit was light), the A11 cell group contained
Table 1 | Calculated numbers of putative dopaminergic neurons that project to the dlPAG and relative contribution of the different cell groups.
Dopaminergic cell groups cases PAGdl injections Control injection
R22 R23 R25 R26 R30 R29
A15
Ventral hypothalamus
0 (0%) 2 (2%) 0 (0%) 2 (1%) 0 (0%) 0 (0%)
A14
Periventricular hypothalamus
18 (10%) 3 (3%) 1 (3%) 20 (15%) 0 (0%) 0 (0%)
A13
Medial zona incerta
110 (59%) 51 (50%) 20 (69%) 61 (45%) 28 (78%) 3 (50%)
A11
Dorso-posterior
hypothalamus
Periventricular gray
16 (9%) 12 (12%) 8 (28%) 14 (10%) 8 (22%) 0 (0%)
A10
Posterior hypothalamic area
Rostral linear raphe nucleus
Ventral periaqueductal gray
40 (22%) 31 (30%) 0 (0%) 36 (26%) 0 (0%) 3 (50%)
A9
Substantia nigra
0 (0%) 3 (3%) 0 (0%) 4 (3%) 0 (0%) 0 (0%)
TOTAL 182 104 29 137 36 6
The measurements were obtained from 3:5 series for the cases with dlPAG injections, and from 1:5 for the control case (R29). The estimated numbers were
calculated by using the Abercrombie correction. For each case, the relative contribution of the different dopaminergic cell groups was calculated as a percentage of
double-labeled neurons estimated in the specific region, divided by the estimated total number of double-labeled neurons.
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FIGURE 3 | Double-labeled neurons in the A13 dopaminergic cell
group projecting to the dlPAG. (A) Diagrammatic representation of
the distribution of CTb/TH-positive cells in the A13 cell group, cases
R22 (black dots) and R30 (red dots). Figures modified from Paxinos and
Watson (1998). (B) Fluorescence micrographs showing TH-labeled
(green) and CTb-labeled neurons (red) in the A13 group in case R22.
Double-labeled neurons appear yellow in the merged image (white
arrows). Scale bar is 60μm.
the second highest number of CTb/TH-positive cells (28% of
the total number of double-labeled neurons for R25, and 22%
for R30) with no double-labeled neurons found in the extended
A10 cell group. The A11 dopaminergic cell group appears at
Bregma level −3mm where it intermingles with the caudal A13
group. However, dopaminergic cells within the A11 cell group
(Figure 4B) can easily be distinguished by their large somata. A
few CTb/TH-positive neurons were located in this group.
A10 cell group. Double-labeled neurons were found in three
distinct parts of the extended A10 cell group: The posterior
hypothalamic area (PHA) illustrated in Figure 5A; and the rostral
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FIGURE 4 | Double-labeled neurons in the A11 dopaminergic cell group
projecting to the dlPAG. (A) Distribution of CTb/TH-positive cells in the A11
cell group, cases R22 (black dots) and R30 (red dots). Figures modified from
Paxinos and Watson (1998). (B) Fluorescence micrographs showing
TH-labeled (green) and CTb-labeled neurons (red) in the A11 group in case
R22. Double-labeled neurons appear yellow in the merged image (white
arrows). Scale bar is 50μm.
linear nucleus of the raphe (RLi) and the ventral periaqueductal
gray (vPAG) represented in Figure 5B. Labeled neurons were
equally distributed among those three sites. Rostrally, they were
located ventral to the third ventricle between the mammil-
lotegmental tract and the fasciculus retroflexus and extended into
the RLi and the vPAG. The ventral tegmental area was devoid
of any retrogradely labeled neurons. Figure 5C shows double-
labeled neurons in the RLi of case R22. In three cases (R22, R23,
and R26), the A10 cell group was the second source of CTb/TH-
positive cells with respectively 22, 30, and 26%of the total number
of double-labeled neurons. These were the cases in which the
injection site was quite large and/or involved the intermediate
part of the dlPAG.
Other cell groups. In all cases, except R30, double-labeled
neurons were also observed in the A14 group. Very few double-
labeled cells were found in the A15 and A9 (substantia nigra)
groups in R23 and R26. Their injection sites shared similari-
ties with tracer spread into the intermediate/caudal dlPAG and
the SC.
Control case. In case R29, the tracer deposit was located in the
deep layers of the SC at the level of the intermediate dlPAG. By
using the same calculations as for dlPAG cases, we found an esti-
mated number of 6 double-labeled neurons. Double-labeled cells
were found in equal numbers in the A13 and the A10 cell groups
(data not shown).
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FIGURE 5 | Double-labeled neurons in the A10 dopaminergic cell group
projecting to the dlPAG. (A) Distribution of CTb/TH-positive cells in the
posterior hypothalamic area (PHA), case R22 (black dots) and R30 (red dots).
Figures modified from Paxinos and Watson (1998). (B) Distribution of
double-labeled neurons in the rostral linear nucleus of the raphe and the
ventral PAG. Figures modified from Paxinos and Watson (1998). (C)
Fluorescence micrographs showing TH-labeled (green) and CTb-labeled
neurons (red) in the rostral linear nucleus in case R22. Double-labeled
neurons appear yellow in the merged image (white arrows). Scale bar is
100μm.
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DOPAMINERGIC PROJECTION FROM A13 TO THE dlPAG
The findings described in the previous section indicate that the
A13 cell group is the main source of dopaminergic input to
the dlPAG. In order to confirm the retrograde tracing data, the
anterograde tracer BDA was injected into the mZI, and sections
containing the mZI and the dlPAG were double stained for TH
and BDA. Figure 6 shows a representative example of a BDA
injection site, within the mZI, overlapping with the A13 cell
group area as illustrated by the presence of BDA/TH-positive neu-
rons. Examination of double-labeled axons and boutons within
the dlPAG confirmed the presence of BDA/TH-immunoreactive
profiles (Figure 7).
DISCUSSION
This study aimed at establishing a dopaminergic map of the
dlPAG, an important brain region involved in the expression of
defensive behavior and panic. The present findings provide evi-
dence for the existence of a relatively abundant dopaminergic
innervation in the dlPAG and demonstrate that this innervation
originates from different areas of the diencephalon and mes-
encephalon. The incertohypothalamic dopamine neurons (A13)
located in the rostromedial part of the zona incerta (mZI) repre-
sents the main source of dopaminergic input to the dlPAG. The
extended A10 group was the second-largest source of dopaminer-
gic input to the dlPAG; the projecting neurons were located in the
PHA, the RLi and the vPAG. Projections from other hypothalamic
groups (A11 and A14) were also identified.
METHODOLOGICAL CONSIDERATIONS
We determined the origin of dopaminergic afferents to the dlPAG
and evaluated the relative contribution of the different dopamin-
ergic groups. The use of retrograde tracing combined with double
immunofluorescence is a reliable and sensitive method which,
however, has some limitations.
The first one is related to the uptake of tracer by fibers of pas-
sage. We opted for injecting relatively large amounts of retrograde
tracer by pressure injection. This allowed us to obtain large injec-
tion sites that cover an important part of the rostro-caudal extent
of the dlPAG. In case of large pressure injection, however, it is pos-
sible that the tracer is taken up also by damaged passing fibers.
This could lead to retrogradely labeled neurons in regions that
actually do not project to the injection site (Chen and Aston-
Jones, 1995). However, several arguments consolidate the results
obtained from our pressure injection cases.
Firstly, we used one case (R30) in which the tracer had been
delivered iontophoretically into the dlPAG. We used a relatively
high current (5μA) to obtain a tracer deposit that would give
strong labeling while still being restricted to the injection site.
The iontophoresis method has been shown to be more sensi-
tive than pressure injection (Kovács and Palkovits, 2010), and
this current intensity (5μA) with CTb has been successfully uti-
lized recently (Bienkowski and Rinaman, 2013). The comparison
between this case (R30) and a case with pressure delivery of
the tracer (R22) confirms the importance of the A13 and A11
dopaminergic groups in the innervation of the dlPAG.
Secondly and most importantly, we selected cases in which
the patterns of CTb deposits were diverse and complementary.
For instance, in cases R23 and R26, injection sites located in
the more caudal part of the dlPAG are complementary to case
R22. The topographies of the different cases were quite similar.
Additionally, all the regions in which a high number of double-
labeled neurons were found (the A13, A11, and A10 groups)
have been shown to project to the dlPAG in previous studies (see
below).
Therefore, if there was any uptake of CTb by passing fiber, it is
likely to be rather limited. In two cases (R23 and R26), we found
a low number of neurons within the A15 and A9 cell groups. Two
neurons in the A15 cell group for each case, and three and four
labeled neurons in the A9 cell group for R23 and R26 respec-
tively. This labeling could be the result of CTB uptake by fibers
of passage, since there are no established projections from the
substantia nigra to the dlPAG (Kirouac et al., 2004).
Another drawback of tracer delivery by pressure injection is
that the tracer can spread out of the limits of the region of
interest. In our study, CTb deposits were also present in the
SC, essentially the deep layers. The SC also contains dopamin-
ergic fibers although less than the dlPAG (Kitahama et al.,
2000) as confirmed by comparison of our TH and DBH stain-
ings. Importantly, the analysis of case R29, in which the tracer
deposit is located only in the deep layers of the SC, shows
that only very few CTb/TH-positive neurons are present in
dopaminergic cell groups (the A13 and A11 cell groups). CTb
deposit spread also into a small portion of the dorsomedial PAG
FIGURE 6 | BDA injection site in the area of the mZI, including the A13 cell group. Images from fluorescent microscopy show neurons containing the
anterograde tracer (in red) and TH in (green). Double-labeled cells are indicated by arrows and appear in yellow. Scale bar is 30μm.
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FIGURE 7 | BDA-labeled terminals and terminal boutons in the dlPAG
originating from the A13 dopaminergic cell group. Upper panel: images
from confocal microscopy showing BDA- (in green) and TH-labeled fibers (in
red) in the dlPAG. Arrowheads indicate double-labeled processes. Middle and
lower panels: high magnification images of double-labeled processes.
Arrowheads indicate double labeling. Scale bar is 10μm.
(dmPAG); therefore it is possible that some of the double-labeled
neurons found are actually projecting to the dmPAG which
also plays an important role in defensive behavior (Canteras,
2002).
To provide further evidence that the A13 cell group is a source
of dopaminergic input to the dlPAG, the anterograde tracer BDA
was injected into this area. We choose the high molecular weight
BDA (10,000mW) which is preferentially transported antero-
gradely (Reiner et al., 2000). Given the advantage of BDA of being
able to be delivered also by pressure injection, we preferred this
tracer over Phaseolus vulgaris leucoagglutinin. Thus, we could
apply large injections that covered most part of the A13 group
extent.
A13 CELL GROUP
In this study, the A13 dopaminergic cell group provides most
of the dopaminergic input to the dlPAG. Approximately half
of the total number of CTb/TH-positive neurons was found
in this dopaminergic cell group. It seems that this cell group
projects along a large part of the rostro-caudal extent of the
dlPAG. Indeed, among the cases selected, there were different
patterns of tracer deposit along the dlPAG extent, and in all
cases the A13 dopaminergic cell groups contained most of the
double-labeled neurons. The A13 cell group consists of a clus-
ter of dopaminergic neurons located in the rostromedial part
of the mZI (Björklund et al., 1975) and belongs to the medial
hypothalamic system (Sita et al., 2007). The connection pattern
of the mZI is different from the rest of the zona incerta (ZI)
which is considered to be part of the subthalamic area. Earlier
studies have demonstrated the existence of important recipro-
cal connections between the ZI and the PAG (Shammah-Lagnado
et al., 1985; Kolmac et al., 1998), and provided more detail con-
cerning the topography of these projections and the density of
the anatomical connections between the mZI/A13 and the dlPAG
(Wagner et al., 1995; Geerling et al., 2010). Recently, it has been
confirmed that the dmPAG and dlPAG were among the main
efferents of the incerto-hypotalamic area, and particularly of the
mZI containing the A13 dopaminergic cell group (Sita et al., 2007;
Geerling et al., 2010). The neurochemical nature of these con-
nections has been addressed for melanin-concentrating-hormone
(MCH) and neuropeptide EI (NEI) (Elias and Bittencourt, 1997).
No prior studies have specifically investigated the projection
profile of dopaminergic neurons within the mZI to the PAG.
Considering that dopamine is present in a distinct neuronal
population than the MCH/ NEI-positive neurons (Sita et al.,
2003), it is likely that it targets different neurons and partici-
pates, at least in part, in different physiological processes than
the MCH/NEI-containing neurons. The A13 cell group has pre-
viously been shown to also project to the central nucleus of the
amygdala (Eaton et al., 1994), which is involved in the expres-
sion of fear and other emotional behaviors (Davis, 2000; LeDoux,
2000).
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To our knowledge, no study has yet attempted to relate
the A13 cell group to defensive or panic-like behaviors. It
is known that this dopaminergic cell group projects to other
regions that belong to the defense system such as the medial
preoptic area and the ventromedial hypothalamus (VMH)
(Wagner et al., 1995; Dominguez and Hull, 2005; Miller and
Lonstein, 2009). The VMH is a crucial center for the induc-
tion of defensive behaviors (Fuchs et al., 1985; Canteras,
2002) and dopamine agonists are known to facilitate VMH
stimulation-induced defensive attack in the cat (Maeda et al.,
1985; Sweidan et al., 1990). Similarly, in the medial preop-
tic area-anterior hypothalamus, dopamine, via the D2-receptor,
facilitates affective defense behaviors in cats (Sweidan et al.,
1991). It has been proposed that dopamine could facilitate
defensive responses in the hypothalamus, which would in turn
facilitate dlPAG action (Siegel et al., 1999). We found in the
present study that the A13 dopaminergic cell group directly
innervates the dlPAG. This is intriguing and suggests that
dopamine could act directly on the dlPAG, thus exerting a simul-
taneous action on the different components of the defensive
system.
A11 CELL GROUP
In all cases studied, we found CTb/TH-positive cells in the
A11 dopaminergic cell group located in the dorso-posterior
hypothalamus. This cell group is in direct continuation with
the A13 cell group. Our finding that the rostral and caudal
CTb deposits always resulted in the presence of doubled-labeled
neurons in this cell group indicates that these dopaminergic
neurons project along the entire rostro-caudal extent of the
dlPAG, similarly to the A13 neurons. In Beitz’ study of the
afferents of the different columns of the PAG (Beitz, 1982),
injection of horseradish peroxidase into the dorsolateral sub-
division resulted in labeled cells in the dorsal hypothalamic
area and the PHA. The latter region contained retrogradely
labeled neurons at both the ipsilateral and contralateral sides
when the tracer had been injected into the rostral part of
the dlPAG. Thus, our finding of equivalent number of CTb-
labeled neuron in both hemispheres is in accordance with these
observations.
EXTENDED A10 CELL GROUP
The extended A10 cell group is an assembly of neurons located
near the ventral tegmental area, and includes the PHA, the RLi,
and the vPAG (Miller and Lonstein, 2009). In the present study,
we found TH/CTb-positive neurons in all three subregions.
Previous studies have shown reciprocal connections between
the PHA and the PAG (Beitz, 1982; Abrahamson and Moore,
2001). The PHA mostly sends glutamatergic input to the PAG
(Beart et al., 1990). However, there is a subset of PHA-neurons
that contain TH (Abrahamson and Moore, 2001). These neu-
rons most likely belong to the extended A10 dopaminergic
cell group and project to the dlPAG. The PHA mediates sev-
eral different functions such as nociception (Manning and
Franklin, 1998) and the regulation of heart rate and blood pres-
sure (Spencer et al., 1990) which are thought to be related to
defensive reactions. Most importantly, there is evidence of its
direct implication in defense and panic mechanisms. Like the
posterior hypothalamus, the PHA is connected to the medial
hypothalamic defense system (Canteras, 2002) and stimula-
tion of this area provokes panic attacks in humans (Shekhar
et al., 1990) and panic-like behavior in rats (Rasche et al.,
2006).
The RLi is known to send very few projections to the dlPAG
(Del-Fava et al., 2007). In their study, injection of the antero-
grade tracer Phaseolus vulgaris leucoagglutinin gave a very light
labeling in the dlPAG, suggesting that a limited number of neu-
rons in the RLi project to this column of the PAG. In the present
study, we also found limited numbers of CTb/TH-positive cells
in the RLi. It is therefore tempting to hypothesize that these few
fibers originating from the RLi found in the Del-Fava et al. study
are dopaminergic. The scarce innervation of the dlPAG suggests a
very discrete and specific action by the dopaminergic neurons of
the RLi. So far there is no strong evidence of an implication of the
RLi in defensive behavior or panic.
Finally, we found double-labeled neurons in the vPAG. This is
in agreement with another study stating that the dopaminergic
neurons present in the vPAG also project within the PAG (Hache
et al., 2011), and innervate the dlPAG.
CONCLUSIONS AND FUNCTIONAL IMPLICATIONS
Our combined anatomical tracing and transmitter identification
study constitutes a first step toward a better understanding of the
role of dopamine in the dlPAG and might provide a chemical and
structural basis for the processing of panic-like defensive behav-
ior. The findings demonstrate two main dopaminergic systems
projecting to the dlPAG. The first is located in the hypotha-
lamus and includes the A13, A11, and A14 cell groups. The
second system is the extended A10 dopaminergic cell group of
the ventral midbrain. Besides, two areas of the extended A10
dopaminergic cell group, the PHA and the vPAG, are directly
involved in different aspects of defensive and panic behaviors.
Interestingly, the main source of dopaminergic input to the
dlPAG, the A13, is known to possibly influence the defense system
of the hypothalamus.
This study demonstrates the complex organization of
dopaminergic projections to the dlPAG. Further anatomical
and functional studies are needed to determine whether the
hypothalamic and the mesencephalic projections contact the
same neurons within the dlPAG or whether they target different
populations of neurons. This would help to classify the different
inputs and together with behavioral and pharmacological stud-
ies provide insight concerning a potential role of dopamine in
the mechanisms underlying the expression of defense and panic
behavior. Several neurotransmitters have been shown to medi-
ate the process of defensive behavior and panic in the dlPAG.
Among them, the most studied are serotonin, cholecystokinin,
glutamate and GABA. Recently, others neurotransmitters have
been shown to participate in dlPAG functioning as well (Fogaça
et al., 2012). It is likely that dopamine plays a role in regulating
the expression of dlPAG-mediated panic and defensive reactions,
considering the origin of its input as well as the established role
of dopamine in mediating these behaviors in other parts of the
defense system.
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